Risk-adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real-world report on 141 consecutive Swedish patients
| Image |  |
|---|---|
| Description | scientific article published on 10 August 2020 |
| Author/s |
author: Lotta Hansson Maria Winqvist |
| Publication date | August 10, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |